ArticleFrontiers in pediatrics2026
AutoGluon-based interpretable machine learning for clinical risk stratification of retinopathy of prematurity in very preterm infants.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Retinopathy of prematurity (ROP) remains an important cause of preventable visual impairment in preterm infants. Current screening relies primarily on gestational age and birth weight, which may not fully capture the heterogeneous postnatal clinical course of very preterm infants. This study aimed to develop and internally validate an interpretable machine-learning framework using routinely collected clinical variables for clinical-course-based in-hospital ROP risk stratification. Methods: A total of 236 infants were retrospectively included, comprising 106 infants with ROP and 130 infants with normal ROP screening findings during hospitalization. Fifteen routinely collected maternal and neonatal clinical variables were used in stratified five-fold internal validation. Within each fold, AutoGluon trained 13 individual candidate models and automatically constructed its built-in WeightedEnsemble_L2 from selected base-model predictions. Missing-data imputation and classification-threshold selection were performed within the training data of each fold. A separate 15-predictor LightGBM model was trained using the same clinical-variable framework and evaluated for TreeSHAP-based interpretation and local research-prototype implementation. Results: WeightedEnsemble_L2 was selected as the primary analytical model because of its overall discrimination and screening-oriented performance. It achieved an AUC of 0.823, sensitivity of 0.764, specificity of 0.677, positive predictive value of 0.659, and negative predictive value of 0.779. The Brier score was 0.171, with a calibration intercept of -0.095 and a calibration slope of 1.046. In the separately trained LightGBM model, mechanical ventilation duration, oxygen therapy duration, birth weight, bronchopulmonary dysplasia, length of hospital stay, and prematurity-related encephalopathy were the most influential predictors. Discussion: The proposed framework provides an interpretable, clinical-course-based approach to in-hospital ROP risk stratification by integrating routinely collected NICU data. It may enhance individualized risk assessment by incorporating clinical-course information beyond conventional static birth characteristics. Multicenter external and prospective validation is warranted to further evaluate its clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.